Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cytosorbents Corporation - Common Stock
(NQ:
CTSO
)
0.6051
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.6051
Bid (Size)
0.6100 (100)
Ask (Size)
0.8100 (100)
Prev. Close
0.6051
Today's Range
0.6051 - 0.6051
52wk Range
0.4992 - 1.390
Shares Outstanding
54,679,569
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cytosorbents (CTSO) Q4 2025 Earnings Transcript
↗
March 26, 2026
Cytosorbents (CTSO) Q4 2025 Earnings Transcript
Via
The Motley Fool
CytoSorbents Corp (NASDAQ:CTSO) Reports Q4 2025 Earnings Miss, Stock Declines
↗
March 25, 2026
Via
Chartmill
Topics
Earnings
Performance
YTD
-7.7%
-7.7%
1 Month
+3.8%
+3.8%
3 Month
-10.6%
-10.6%
6 Month
-22.5%
-22.5%
1 Year
-35.6%
-35.6%
More News
Read More
Top movers in Tuesday's pre-market session
↗
December 23, 2025
Via
Chartmill
Cytosorbents Corp (NASDAQ:CTSO) Posts Mixed Q3 2025 Results Amidst Stock Volatility
↗
November 13, 2025
Via
Chartmill
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
CytoSorbents's Earnings: A Preview
↗
May 13, 2025
Via
Benzinga
Cytosorbents (CTSO) Q3 2025 Earnings Transcript
↗
November 13, 2025
Via
The Motley Fool
Deep Dive Into CytoSorbents Stock: Analyst Perspectives (5 Ratings)
↗
September 16, 2025
Via
Benzinga
Wednesday's pre-market session: top gainers and losers
↗
August 20, 2025
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 20, 2025
Via
Benzinga
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
↗
August 20, 2025
Via
Benzinga
Demystifying CytoSorbents: Insights From 5 Analyst Reviews
↗
August 08, 2025
Via
Benzinga
CytoSorbents Corp (NASDAQ:CTSO) Reports Mixed Q2 2025 Earnings with Revenue Beat and Narrower Loss
↗
August 07, 2025
Via
Chartmill
A Glimpse Into The Expert Outlook On CytoSorbents Through 5 Analysts
↗
July 21, 2025
Via
Benzinga
Top movers in Wednesday's session
↗
July 02, 2025
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 02, 2025
Via
Benzinga
These stocks are moving in today's session
↗
July 02, 2025
Via
Chartmill
Gapping stocks in Wednesday's session
↗
July 02, 2025
Via
Chartmill
Deep Dive Into CytoSorbents Stock: Analyst Perspectives (6 Ratings)
↗
June 25, 2025
Via
Benzinga
Demystifying CytoSorbents: Insights From 4 Analyst Reviews
↗
May 02, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 02, 2025
Via
Benzinga
Earnings Scheduled For May 14, 2025
↗
May 14, 2025
Via
Benzinga
The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts
↗
April 01, 2025
Via
Benzinga
Earnings Scheduled For March 31, 2025
↗
March 31, 2025
Via
Benzinga
Frequently Asked Questions
Is Cytosorbents Corporation - Common Stock publicly traded?
Yes, Cytosorbents Corporation - Common Stock is publicly traded.
What exchange does Cytosorbents Corporation - Common Stock trade on?
Cytosorbents Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytosorbents Corporation - Common Stock?
The ticker symbol for Cytosorbents Corporation - Common Stock is CTSO on the Nasdaq Stock Market
What is the current price of Cytosorbents Corporation - Common Stock?
The current price of Cytosorbents Corporation - Common Stock is 0.6051
When was Cytosorbents Corporation - Common Stock last traded?
The last trade of Cytosorbents Corporation - Common Stock was at 05/05/26 04:00 PM ET
What is the market capitalization of Cytosorbents Corporation - Common Stock?
The market capitalization of Cytosorbents Corporation - Common Stock is 33.09M
How many shares of Cytosorbents Corporation - Common Stock are outstanding?
Cytosorbents Corporation - Common Stock has 33M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
